BNET Industries

IVAX Corp.

  • Public
Dow Jones Description

In January 2006 the company was acquired by Teva Pharmaceutical Industries Ltd of Jerusalem, Israel.

Contact Information
NAICS Code : 541710

Recent Events

  • Heavy hitters invest $31M in Opko

    6/02/09 - Merger / Acquisition - View Story

News & Analysis

fda and ivax corp. - All News and Analysis

  • IVAX Receives Final Approval on 600 and 800 mg Gabapentin Tablets

    - 2005-05-02

    MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that it received final approval on April 29, 2005 from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for gabapentin 600 and 800 mg tablets. Upon FDA approval, IVAX' wholly owned subsidiary, IVAX Pharmaceuticals, Inc.,...

    Tags: FDA, IVAX Corp., tablet

  • IVAX Receives Final FDA Approval for Anagrelide HCl Capsules

    - 2005-04-18

    MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) has received final approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for anagrelide HCl capsules in 0.5 and 1 mg dosage strengths. This product will be sold through IVAX' wholly owned subsidiary, IVAX Pharmaceuticals, Inc....

    Tags: FDA, IVAX Corp.

  • IVAX Receives New Drug Approval for Proprietary Asthma Product

    - 2004-11-01

    MIAMI -- IVAX Corporation (AMEX: IVX, LSE: IVX.L) received approval from the United States Food and Drug Administration FDA for its New Drug Application NDA for its patented HFA (CFC-free) formulation of albuterol in a metered dose inhaler MDI for the treatment of asthma. The product will be marketed by...

    Tags: FDA, IVAX Corp.

  • IVAX Receives FDA Approvable Letter for Albuterol HFA in Breath-Activated Inhaler

    - 2004-07-07

    MIAMI -- IVAX Corporation (AMEX:IVX)(LSE:IVX.L) announced today that it has received an approvable letter from the United States Food and Drug Administration FDA for its New Drug Application NDA for albuterol sulfate using non-ozone-depleting, CFC-free propellant in IVAX' patented breath-activated aerosol inhaler.

    Tags: FDA, IVAX Corp.

  • U.S. District Court Extends TRO Against FDA Until November 21st

    - 2003-11-18

    Business Editors/Health/Medical Writers MIAMI--BUSINESS WIRE--Nov. 18, 2003 IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced that the U.S. District Court in Washington D.C. has extended its temporary restraining order against the United States Food and Drug Administration ("FDA") in the Metformin ER case for three more days, ending at the close...

    Tags: FDA, Government, IVAX Corp., U.S. District Court

Decision Makers

Name (plus bio) Position
Neil W. Flanzraich President
Jimmy Wang CIO & Vice President
Nicholas Bodor Chief Scientific Officer
Thomas E. Beier CFO & Senior Vice President, Finance
Thomas E. McClary Chief Accounting Officer
Rafick Henein Senior Vice President
Steven D. Rubin General Counsel, Senior Vice President & Secretary
Edmund Fry Vice President, Compliance
J. Michael Lopez Vice President, HR
Michael M. Lopez Vice President, HR
Rao Uppaluri Vice President, Strategic Planning
Roberto Prego Vice President, Latin America
Stephen Sheriff Vice President, Taxation & Tax Counsel
David Malina Director, Investor Relations & Corp Communications
Hans Berner Soto Director, Operations, Latin America

Organization Position Status
IVAX Corporation President Current
Equity One, Inc. Vice Chairman and President Current
BELLUS Health Inc. Consultant Current
RAE Systems Inc. Member, Chair Current
Equity One, Inc. Board of Directors Current
Continucare Corporation Director Current
Chipotle Mexican Grill, Inc. Director Current
BELLUS Health Inc. Director Current
IVAX Corporation Vice Chairman Current
Harvard College A.B Former
Heller Ehrman LLP Life Sciences Legal Practice Group Team Former
Syntex Corporation Former
Israelamericafoundation.Com Chairman Former
RAE Systems Inc. Board of Directors Former
Harvard Law School J.D. Former
Harvard College A.B. Former

Organization Position Status
IVAX Corporation CIO & Vice President Current

Organization Position Status
IVAX Corporation Chief Scientific Officer Current

Organization Position Status
IVAX Corporation CFO & Senior Vice President, Finance Current
IVAX Diagnostics, Inc. Cfo Former

Organization Position Status
IVAX Corporation Chief Accounting Officer Current
IVAX Diagnostics, Inc. Vice President, Finance Current

Organization Position Status
IVAX Corporation Senior Vice President Current
Bioxelpharma Inc. Board of Directors Current
Ontario College of Pharmacists Board of Directors Current
Geopharma, Inc. Director Current
Dex-C20 Director Current
Ontario College of Pharmacists Member Current
IVAX Pharmaceuticals Inc. President & CEO Former
Novopharm Limited Chief Operating Officer Former
Novopharm Limited Executive Vice President Former
McGill University Diploma In Management Former
McGill University MBA Former
McGill University Diploma In Management Former

Organization Position Status
IVAX Corporation General Counsel, Senior Vice President & Secretary Current

Organization Position Status
IVAX Corporation Vice President, Compliance Current

Organization Position Status
IVAX Corporation Vice President, HR Current

Organization Position Status
IVAX Diagnostics, Inc. Vice President, HR Current
IVAX Corporation Vice President, HR Current

Organization Position Status
IVAX Corporation Vice President, Strategic Planning Current
IVAX Diagnostics, Inc. Vice President, Strategic Planning Current

Organization Position Status
IVAX Corporation Vice President, Latin America Current
IVAX Diagnostics, Inc. Vice President Current

Organization Position Status
IVAX Diagnostics, Inc. Vice President Current
IVAX Corporation Vice President, Taxation & Tax Counsel Current

Organization Position Status
IVAX Corporation Director, Investor Relations & Corp Communications Current
IVAX Corporation Director, Investor Relations & Corp Communications Former

Organization Position Status
IVAX Corporation Director, Operations, Latin America Current
advertisement
IndustryTop Rated
advertisement